
Andres Chang MD PhD
Hematologic Oncology
Assistant Professor, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University
Join to view full profile
1365 Clifton Rd NE C4005CAtlanta, GA 30322
Phone+1 404-778-1900
Dr. Chang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Andres Chang, MD, is a hematology specialist based in Atlanta, GA, with subspecialties in hematologic oncology. He completed his fellowship in Hematology and Medical Oncology and residency in Internal Medicine at Emory University School of Medicine, after earning his MD PhD with high honors from the University of Kentucky College of Medicine. Dr. Chang serves as an Assistant Professor at Emory Clinic and has amassed experience in chronic lymphoid leukemia, lymphoma, and classical hematology. He has published several academic articles, notably in prestigious journals such as the Proceedings of the National Academy of Sciences, Journal of Clinical Oncology, and the Journal for Immunotherapy of Cancer.
Education & Training
Emory UniversityMSCR, Master's of Science in Clinical Research, 2024 - 2025
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2020
Emory University School of MedicineResidency, Internal Medicine, 2014 - 2016
University of Kentucky College of MedicineClass of 2014, MD PhD, High Honors
Certifications & Licensure
GA State Medical License 2020 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsImmunogenic cell death unlocks the potential for combined radiation and immunotherapy.Somiya Rauf, Alexandra Smirnova, Andres Chang, Yuan Liu, Yi Jiang
Proceedings of the National Academy of Sciences of the United States of America. 2025-12-02 - 1 citationsPD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy.Andres Chang, Adam N Pelletier, Donald J McGuire, Maria Tsagiopoulou, Maria Karipidou
Proceedings of the National Academy of Sciences of the United States of America. 2025-09-09 - In the time of COVID-19: challenges, successes, and lessons learned from studies in cancer patients.Philip C Mack, James M Crawford, Andres Chang, Anna Yin, Sabra L Klein
Journal of the National Cancer Institute. 2025-08-01
Press Mentions
Andres Chang, MD, PhD, and Rafi Ahmed, PhD, on Immune Responses After COVID Vaccination in NHL/CLL PatientsOctober 26th, 2022
Influenza Vaccination Status in DLBCL Poorly DocumentedJuly 5th, 2019
Grant Support
- SARS-CoV-2 immune responses in patients with lymphomaEMORY UNIVERSITY2024–2029
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









